Creative Financing Approaches in Life Science
By , , ,

This article is the third in a 4-part series reviewing financing solutions for the Life Science sector. As Life Science company valuations have fluctuated significantly over the last two years, and investors have become cautious due to economic turbulence and market uncertainty, fundraising is taking longer. Equity financing has been…Read More

Read More
How to Successfully Extend the Cash Runway to Growth in Early Commercial Stage Life Science Companies
By ,

This article is the second in a 4-part series reviewing financing solutions for the Life Science sector. Life Science venture capital and private equity-funded startups are constantly chasing capital to extend operating cash runways, driving value inflection milestones such as clinical trial data and funding growth for commercial-stage entities. Understandably,…Read More

Read More
The Startup’s Dilemma: Planning for Success vs. Conserving Cash
By

Having spent the past 12 years as a Life Sciences and Technology CFO consulting to venture and private-equity backed companies, I have seen a consistent and recurring dilemma faced by these emerging companies: the struggle between planning for success and conserving cash. The age-old adage “you have to spend money…Read More

Read More
Pre-Acquisition Planning for Post-Acquisition Integration
By

As all CEOs and management teams know, there are many challenges to successfully completing an acquisition. These range from identifying the right acquisition target through complex target-acquirer negotiations and ultimately to finalizing terms and closing the deal.  But one of the challenges of M&A that often doesn’t get enough attention…Read More

Read More